ArcticZymes Technologies ASA (OSL:AZT)

Norway flag Norway · Delayed Price · Currency is NOK
23.70
-0.30 (-1.25%)
At close: Mar 2, 2026
29.08%
Market Cap 1.21B
Revenue (ttm) 118.21M
Net Income (ttm) 9.88M
Shares Out 51.07M
EPS (ttm) 0.19
PE Ratio 124.74
Forward PE 57.87
Dividend n/a
Ex-Dividend Date n/a
Volume 32,788
Average Volume 50,814
Open 23.50
Previous Close 24.00
Day's Range 23.10 - 23.70
52-Week Range 14.00 - 31.40
Beta 0.35
RSI 57.75
Earnings Date Feb 12, 2026

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 53
Stock Exchange Oslo Børs
Ticker Symbol AZT
Full Company Profile

Financial Performance

In 2025, OSL:AZT's revenue was 118.21 million, an increase of 9.34% compared to the previous year's 108.11 million. Earnings were 9.88 million, an increase of 16.66%.

Financial Statements

News

There is no news available yet.